ADDF draws the reviewers for its grant selection from two different bodies: the Scientific Review Board and the Business Advisory Board. The Scientific Review Board is composed of over 150 scientists who encompass various areas of expertise within AD research and also include scientists overseas. The Business Advisory Board comprises members from various backgrounds, including venture capital and the biotechnology and pharmaceutical industry.
| Thomas Cirrito, PhD Stemline Therapeutics, Inc. Long Island City, NY |
John K. Clarke Cardinal Partners Princeton, NJ |
| Mark A. Cochran, PhD Biotechnology Business Development Charlottesville, VA |
Steven G. Dickman CBT Advisors Cambridge, MA |
| Steven Dyson Apax Partners, Ltd. London, England |
Julie Eskay-Eagle September Ventures LLC Armonk, NY |
| Stephen M. Goodman, Esq. Pryor Cashman Sherman & Flynn, LLP New York, NY |
Allan Green, MD, PhD, JD Allan M. Green Esq., LLC Cambridge, MA |
| Elaine Jones, PhD EuclidSR Partners New York, NY |
Perry Karsen Celgene Corporation Summit, NJ |
| Glenn J. Kline Academy Funds Research Triangle Park, NC |
Larry Kunstadt, PhD National Securities Corp New York, NY |
| Emer Leahy, PhD Psychogenics Inc. Hawthorne, NY |
Michael Lefenfeld SiGNa Chemeistry, Inc. New York, NY |
| David Lowe, PhD PsychoGenics, Inc. Tarrytown, NY |
Michael Lytton, PhD Oxford Bioscience Partners Boston, MA |
| Brian McCarthy, PhD Influmedix, Inc. Radnor, PA |
Ian Mehr, PhD Golden Pine Ventures, LLC Durham, NC |
| Daniel J. O’Connell NeuroVentures Capital, LLC Charlottesville, VA |
William Paiva Chisholm Private Capital Tulsa, OK |
| Michael Parker BIONEST Partners New York, NY |
Debra Peattie, PhD Valeo Medical Inc. Concord, MA |
| Cathrin Petty Apax Partners & Co. London, England |
Cheryl V. Reicin, PhD Torys Toronto, Ontario, Canada |
| Beth Seidenberg, MD Kleiner Perkins Caufield & Byers Menlo Park, CA |
David W. Summa Technology Pathfinders, LLC Hillsborough, CA |
| Katya Tsaloun, PhD Apredica Watertown, MA |